Digitized Number 2: Stool Samples Reveal Microbial Enzyme Driving Bowel Disease

UC San Diego researchers have identified microbiome-derived proteases in the gut contributing to ulcerative colitis, inspiring new potential drug targets for inflammatory bowel disease.  In a study publishing on January 27, 2022 in Nature Microbiology , researchers at University of California San Diego School of Medicine have identified a class of microbial enzymes that drive ulcerative colitis, and have demonstrated a potential route for therapeutic intervention.